| Dr Dapka Nicholas Baccam, MD | |
|
1801 Hickman Rd, Des Moines, IA 50314-1505 | |
| (515) 282-2598 | |
| (515) 282-3234 |
| Full Name | Dr Dapka Nicholas Baccam |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 29 Years |
| Location | 1801 Hickman Rd, Des Moines, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235136581 | NPI | - | NPPES |
| 1235136581 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 33652 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Guthrie County Hospital | Guthrie center, IA | Hospital |
| Clarke County Hospital | Osceola, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Clarke County Public Hospital | 1951219328 | 27 |
News Archive
Morgan Advanced Materials, a global specialist in the development and manufacture of ultrasonic sensors and transducers, is developing a new non-contact ultrasonic flow sensor which is typically five times more accurate at low flow rates than other ultrasonic sensors available in the medical and laboratory sectors.
It's widely known that the causative agent for COVID-19, the SARS-CoV-2 virus, can spread rapidly among residents in nursing homes and other long-term care facilities, leading to high numbers of cases and deaths in a very vulnerable population.
The Muscular Dystrophy Association today announced 13 new research and development grants totaling $3.5 million to accelerate the development of treatments for muscular dystrophy, ALS and related life-threatening diseases.
A team of scientists from the University of California, San Diego School of Medicine, the Medical University of South Carolina and San Diego-based American Life Science Pharmaceuticals, Inc., report that cathepsin B gene knockout or its reduction by an enzyme inhibitor blocks creation of key neurotoxic pGlu-Aβ peptides linked to Alzheimer's disease (AD). Moreover, the candidate inhibitor drug has been shown to be safe in humans.
› Verified 8 days ago
| Entity Name | Guthrie County Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1366414534 PECOS PAC ID: 6204745110 Enrollment ID: O20030414000048 |
News Archive
Morgan Advanced Materials, a global specialist in the development and manufacture of ultrasonic sensors and transducers, is developing a new non-contact ultrasonic flow sensor which is typically five times more accurate at low flow rates than other ultrasonic sensors available in the medical and laboratory sectors.
It's widely known that the causative agent for COVID-19, the SARS-CoV-2 virus, can spread rapidly among residents in nursing homes and other long-term care facilities, leading to high numbers of cases and deaths in a very vulnerable population.
The Muscular Dystrophy Association today announced 13 new research and development grants totaling $3.5 million to accelerate the development of treatments for muscular dystrophy, ALS and related life-threatening diseases.
A team of scientists from the University of California, San Diego School of Medicine, the Medical University of South Carolina and San Diego-based American Life Science Pharmaceuticals, Inc., report that cathepsin B gene knockout or its reduction by an enzyme inhibitor blocks creation of key neurotoxic pGlu-Aβ peptides linked to Alzheimer's disease (AD). Moreover, the candidate inhibitor drug has been shown to be safe in humans.
› Verified 8 days ago
| Entity Name | Knoxville Community Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770591661 PECOS PAC ID: 6608787056 Enrollment ID: O20031119000804 |
News Archive
Morgan Advanced Materials, a global specialist in the development and manufacture of ultrasonic sensors and transducers, is developing a new non-contact ultrasonic flow sensor which is typically five times more accurate at low flow rates than other ultrasonic sensors available in the medical and laboratory sectors.
It's widely known that the causative agent for COVID-19, the SARS-CoV-2 virus, can spread rapidly among residents in nursing homes and other long-term care facilities, leading to high numbers of cases and deaths in a very vulnerable population.
The Muscular Dystrophy Association today announced 13 new research and development grants totaling $3.5 million to accelerate the development of treatments for muscular dystrophy, ALS and related life-threatening diseases.
A team of scientists from the University of California, San Diego School of Medicine, the Medical University of South Carolina and San Diego-based American Life Science Pharmaceuticals, Inc., report that cathepsin B gene knockout or its reduction by an enzyme inhibitor blocks creation of key neurotoxic pGlu-Aβ peptides linked to Alzheimer's disease (AD). Moreover, the candidate inhibitor drug has been shown to be safe in humans.
› Verified 8 days ago
| Entity Name | Clarke County Public Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023045804 PECOS PAC ID: 1951219328 Enrollment ID: O20040224000636 |
News Archive
Morgan Advanced Materials, a global specialist in the development and manufacture of ultrasonic sensors and transducers, is developing a new non-contact ultrasonic flow sensor which is typically five times more accurate at low flow rates than other ultrasonic sensors available in the medical and laboratory sectors.
It's widely known that the causative agent for COVID-19, the SARS-CoV-2 virus, can spread rapidly among residents in nursing homes and other long-term care facilities, leading to high numbers of cases and deaths in a very vulnerable population.
The Muscular Dystrophy Association today announced 13 new research and development grants totaling $3.5 million to accelerate the development of treatments for muscular dystrophy, ALS and related life-threatening diseases.
A team of scientists from the University of California, San Diego School of Medicine, the Medical University of South Carolina and San Diego-based American Life Science Pharmaceuticals, Inc., report that cathepsin B gene knockout or its reduction by an enzyme inhibitor blocks creation of key neurotoxic pGlu-Aβ peptides linked to Alzheimer's disease (AD). Moreover, the candidate inhibitor drug has been shown to be safe in humans.
› Verified 8 days ago
| Entity Name | Guthrie County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366414534 PECOS PAC ID: 6204745110 Enrollment ID: O20040224001006 |
News Archive
Morgan Advanced Materials, a global specialist in the development and manufacture of ultrasonic sensors and transducers, is developing a new non-contact ultrasonic flow sensor which is typically five times more accurate at low flow rates than other ultrasonic sensors available in the medical and laboratory sectors.
It's widely known that the causative agent for COVID-19, the SARS-CoV-2 virus, can spread rapidly among residents in nursing homes and other long-term care facilities, leading to high numbers of cases and deaths in a very vulnerable population.
The Muscular Dystrophy Association today announced 13 new research and development grants totaling $3.5 million to accelerate the development of treatments for muscular dystrophy, ALS and related life-threatening diseases.
A team of scientists from the University of California, San Diego School of Medicine, the Medical University of South Carolina and San Diego-based American Life Science Pharmaceuticals, Inc., report that cathepsin B gene knockout or its reduction by an enzyme inhibitor blocks creation of key neurotoxic pGlu-Aβ peptides linked to Alzheimer's disease (AD). Moreover, the candidate inhibitor drug has been shown to be safe in humans.
› Verified 8 days ago
| Entity Name | Lucas County Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588636351 PECOS PAC ID: 8921916792 Enrollment ID: O20040317001356 |
News Archive
Morgan Advanced Materials, a global specialist in the development and manufacture of ultrasonic sensors and transducers, is developing a new non-contact ultrasonic flow sensor which is typically five times more accurate at low flow rates than other ultrasonic sensors available in the medical and laboratory sectors.
It's widely known that the causative agent for COVID-19, the SARS-CoV-2 virus, can spread rapidly among residents in nursing homes and other long-term care facilities, leading to high numbers of cases and deaths in a very vulnerable population.
The Muscular Dystrophy Association today announced 13 new research and development grants totaling $3.5 million to accelerate the development of treatments for muscular dystrophy, ALS and related life-threatening diseases.
A team of scientists from the University of California, San Diego School of Medicine, the Medical University of South Carolina and San Diego-based American Life Science Pharmaceuticals, Inc., report that cathepsin B gene knockout or its reduction by an enzyme inhibitor blocks creation of key neurotoxic pGlu-Aβ peptides linked to Alzheimer's disease (AD). Moreover, the candidate inhibitor drug has been shown to be safe in humans.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dapka Nicholas Baccam, MD 1801 Hickman Rd, Des Moines, IA 50314-1505 Ph: (515) 282-2598 | Dr Dapka Nicholas Baccam, MD 1801 Hickman Rd, Des Moines, IA 50314-1505 Ph: (515) 282-2598 |
News Archive
Morgan Advanced Materials, a global specialist in the development and manufacture of ultrasonic sensors and transducers, is developing a new non-contact ultrasonic flow sensor which is typically five times more accurate at low flow rates than other ultrasonic sensors available in the medical and laboratory sectors.
It's widely known that the causative agent for COVID-19, the SARS-CoV-2 virus, can spread rapidly among residents in nursing homes and other long-term care facilities, leading to high numbers of cases and deaths in a very vulnerable population.
The Muscular Dystrophy Association today announced 13 new research and development grants totaling $3.5 million to accelerate the development of treatments for muscular dystrophy, ALS and related life-threatening diseases.
A team of scientists from the University of California, San Diego School of Medicine, the Medical University of South Carolina and San Diego-based American Life Science Pharmaceuticals, Inc., report that cathepsin B gene knockout or its reduction by an enzyme inhibitor blocks creation of key neurotoxic pGlu-Aβ peptides linked to Alzheimer's disease (AD). Moreover, the candidate inhibitor drug has been shown to be safe in humans.
› Verified 8 days ago
Jan Franko, MD, PHD Surgery Medicare: Accepting Medicare Assignments Practice Location: 411 Laurel St, Ste 2100, Des Moines, IA 50314 Phone: 515-247-3266 Fax: 515-643-8688 | |
Ashlea Semmens, MD Surgery Medicare: Medicare Enrolled Practice Location: 1415 Woodland Ave, Ste 140, Des Moines, IA 50309 Phone: 515-241-4076 | |
Dr. Ze-hui Han, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 450 Laurel St, Ste. A, Des Moines, IA 50314 Phone: 515-247-8400 Fax: 515-248-8888 | |
Dr. Yuichi Ishida, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 411 Laurel St Ste A250, Des Moines, IA 50314 Phone: 515-235-5000 Fax: 515-288-6713 | |
Dr. Richard Sidwell, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1212 Pleasant St, Suite 211, Des Moines, IA 50309 Phone: 515-875-9770 Fax: 515-875-9771 | |
Dr. Robert Louis Clark Jr., MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 3600 30th St, Des Moines, IA 50310 Phone: 515-699-5826 Fax: 515-699-5929 | |
Alexander M Stock, MD Surgery Medicare: Medicare Enrolled Practice Location: 1200 Pleasant St, Des Moines, IA 50309 Phone: 515-241-4078 |